Friday, June 12, 2015

Top 5 Medical Companies To Watch In Right Now

Top 5 Medical Companies To Watch In Right Now: FibroGen Inc (FGEN)

FibroGen, Inc. (FibroGen) is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat unmet medical needs. The Company focuses in the areas of fibrosis and hypoxia-inducible factor (HIF) biology. FibroGens products include Roxadustat (FG-4592), which is an oral small molecule inhibitor of HIF prolyl hydroxylases (HIF-PHs), in Phase III clinical development for the treatment of anemia in chronic kidney disease (CKD), and FG-3019, which is a monoclonal antibody in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), pancreatic cancer and liver fibrosis. The Companys subsidiaries include FibroGen Europe Oy (FibroGen Europe) and FibroGen China Anemia Holdings, Ltd. (FibroGen China).

Roxadustat is the HIF-PH inhibitor in Phase III clinical development, which acts by stimulating the bodys natural pathway of erythropoiesis, or red blood cell produc tion. Roxadustat represents a new paradigm for the treatment of anemia in CKD patients and offers injectable erythropoiesis stimulating agents (ESAs). 1,449 subjects have participated in 26 completed Phase I and II clinical studies for roxadustat in North America, Europe and Asia. The Company, along with its collaboration partners, Astellas Pharma Inc., (Astellas) and AstraZeneca AB,(AstraZeneca), has designed a global Phase III program to support regulatory approval of roxadustat in both NDD-CKD and DD-CKD patients in multiple geographies.

FG-3019 is the Companys fully-human monoclonal antibody that inhibits the activity of connective tissue growth factor (CTGF), a critical common element in the progression of fibrosis and associated diseases. In Phase II IPF clinical studies, FG-3019 demonstrated the stabilization of disease and, in human studies, reversal of lung fibrosis in some patients. In an open-label Phase II pancreatic cancer study of FG-301! 9 plus gemcitabine and erlotinib, FG-3019 demonstrated a dose-depen! dent improvement in one year survival rate. In 10 Phase I and Phase II clinical studies of FG-3019 to date involving over 340 subjects, FG-3019 has been tolerated across a range of doses studied, and there have been no dose-limiting toxicities observed as of November 13, 2014.

The Company competes with Threshold Pharmaceuticals, Inc., Gilead Sciences, Inc., Halozyme Therapeutics, Inc., Gilead Sciences, Inc., Celgene Corporation, Janssen Biotech, Inc., Johnson & Johnson, Inc., Sanofi, Novartis and Biogen Idec.

Advisors' Opinion:
  • [By John Udovich]

    Recent IPOFibroGen Inc (NASDAQ: FGEN) surged 22.96% today, reportedly after the journal Hepatology published the results of a workshop between the FDA and the American Association for the Study of Liver Disease (AASLD) which laid out criteria for a phase three study of a treatment for non-alcoholic steatohepatitis (NASH) meaning its worth taking a closer look at the stock along with the performance of potential small cap or mid cap liver disease stock peers like Conatus Pharmaceuticals Inc (NASDAQ: CNAT), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) and Raptor Pharmaceutical Corp (NASDAQ: RPTP) which rose 24.35%, 10.98% and 2.02%, respectively. According to Investors Business Daily, NASH (the more serious version of fatty liver disease) is potentially an enormous market with about 6 millionUS patients but thelack of previous treatments had left it unclear how the FDA would measure success against the disease while FibroGen Inc doesn't yet have a NASH human trial in the works, it has said it hopes to start one for its lead candidate FG-3019 (its in mid-stage trials for pulmonary fibrosis and liver fibrosis due to hepatitis B infection).

  • source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-5-medical-companies-to-watch-in-right-now.html

Thursday, June 11, 2015

Top 10 Medical Stocks For 2016

Top 10 Medical Stocks For 2016: Bio-Path Holdings Inc (BPTH)

Bio-Path Holdings Inc is a development stage company. The Company, through its wholly owned subsidiary, Bio-Path, Inc. is engaged in the business of developing cancer therapeutics. As of December 31, 2011, the Company had licenses from The University of Texas M. D. Anderson Cancer Center (MD Anderson) for three lead products and nucleic acid delivery technology, including tumor targeting technology. The licenses provide drug delivery platform technology with composition of matter intellectual property for antisense that enables systemic delivery of antisense, formulation intellectual property for systemic delivery of small interfering Ribonucleic acid (RNA) (siRNA) and small molecules for treatment of cancer. The Company issued a press release announcing that the United States Food and Drug Administration (FDA) had allowed an IND (investigational new drug) for its lead cancer drug candidate liposomal BP-100-1.01 (or Liposomal Grb-2 or L-Grb-2) to proceed into clinical tria ls.

In February, 2012, the Company completed requirements for treating patients in the second cohort. The dose being used for treatment in the third cohort is double the dose that was used to treat patients in the second cohort. At the end of February, 2012, enrollment continued in the third cohort of the clinical trial and patients are being treated.

BP-100-1.01

BP-100-1.01 is the Company's lead lipid delivery antisense drug candidate, which is being clinically tested in patients having acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), myelodysplastic syndrome (MDS) and acute lymphoblastic leukemia (ALL). Receipt of an IND allowed the Company to commence its Phase I clinical trial to study L-Grb-2 in human patients. Phase I clinical trial is a dose-escalating study to determine the safety and tolerance of escalating doses of L-Grb-2. The clinical trial is being conducted at The University of Texas MD Anders! on Cancer Cen ter. As of December 31, 2011, the trial is in the middle of ! testing the third dose in patients.

BP-100-2.01

BP-100-1.02 is Liposomal Bcl-2 (also L-Bcl-2), another liposomal antisense drug candidate that was licensed from MD Anderson. This drug has pre-clinical testing data package. The target protein for this drug candidate, Bcl-2, is involved in regulating programmed cell death. In cancer, the Bcl-2 protein can over-express, which can lead to a situation, in which the Bcl-2 protein blocks the cells normal death signals, making the cancer cell resistant to chemotherapy. Types of cancer potentially treatable with L-Bcl-2 include lymphoma, prostate cancer, small cell lung cancer, breast cancer, melanoma, chronic lymphoid leukemia (CLL) and several others.

Advisors' Opinion:
  • [By Lisa Levin]

    Bio-Path Holdings (NASDAQ: BPTH) shares declined 5.66% to touch a new 52-week low of $2.50. Bio-Path shares have jumped 349.15% over the past 52 weeks, while the S&P 500 index has gained 19.24% in the same period.

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-10-medical-stocks-for-2016.html

Wednesday, June 10, 2015

5 Best Up And Coming Stocks To Own Right Now

EMCOR Group Inc.�� (EME) subsidiary, S.A. Comunale, was recently awarded a contract for installation of fire protection and mechanical systems at Northeast Ohio Medical University Health and Wellness Center in Rootstown, Ohio, for an undisclosed amount.

With a rich experience in mechanical, fire protection & HVAC (heating, ventilation, and air conditioning) services, S.A. Comunale is a leading player in its category. The company provides services in literally every market sector and facility type and has its branch offices spread across 16 locations across the country.

Under the terms of the agreement, S.A. Comunale will design and install a complete fire protection system for the exterior as well as the interior of the building spread over an area of 176,000 square feet. The company will also be responsible for the installation and design of all related underground plumbing, HVAC and piping systems at Ohio�� new medical facility.

EMCOR has been lately winning back-to-back contracts through its subsidiaries. A couple of days back its subsidiary, EMCOR Government Services, procured a contract to operate and maintain the new headquarters of Coast Guard at the Government Service Administration�� St. Elizabeth's Campus in Washington, D.C.

Hot Cheap Stocks To Watch For 2016: GlaxoSmithKline PLC(GSK)

GlaxoSmithKline plc, together with its subsidiaries, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, HIV, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, oncology and emesis, vaccines, and dermatologicals. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also markets a range of vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. In addition, the company provides OTC medicines, including Panadol, a paracetamol-based treatment of headache and joi nt pain, fever, and cold symptoms; Gaviscon, a range of antacid products that relieve heartburn due to acid reflux; and NicoDerm, NiQuitin CQ, Nicabate, and Nicorette for the treatment of nicotine withdrawal as an aid to quit smoking. Further, it offers oral healthcare products comprising Sensodyne, a range of toothpastes and toothbrushes for the prevention of dental sensitivity; Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes; and Polident, Poligrip, and Corega, which are denture adhesives and cleansers. Additionally, the company provides nutritional healthcare products consisting of Lucozade, an energy and sports drinks for energy and hydration; Horlicks, a malted, milk-based drink and food for nutrition application; and Ribena, an apple, orange, raspberry, and pomegranate flavored fruit drink, as well as markets skincare products. GlaxoSmithKline plc was incorporated in 1999 and is headquartered in Brentford, United Kingdom.

Advisors' Opinion:
  • [By Sean Williams]

    Secondly, Theravance set the course for its upcoming split into two companies: Royalty Management Co., consisting of its FDA-approved COPD assets and other collaborations under partnership with GlaxoSmithKline (NYSE: GSK  ) , and Theravance BioPharma, consisting of every other therapeutic indication in its pipeline. Shareholders on record as of May 15 will receive Theravance BioPharma shares in the form of dividend by June 2.

  • [By Brian Orelli]

    Guilt by association
    Generic Viagra will hurt more than just Pfizer. With a cheap erectile dysfunction drug on the market, patients may be interested in switching from brand-name versions of Eli Lilly's (NYSE: LLY  ) Cialis and Bayer�and GlaxoSmithKline's (NYSE: GSK  ) Levitra. In the U.K., the Globes newspaper reported that Teva will sell the pill for a tenth of the cost of the brand-name drug. That's quite a motivation to switch.

  • [By Holly LaFon]

    Currently the company is partnering with GlaxoSmithKline (GSK) and AstraZeneca (AZN) on an adult hepatitis B vaccine, which has been proven effective in Phase 3 clinical trials.

5 Best Up And Coming Stocks To Own Right Now: Forbes Energy Services Ltd (FES)

Forbes Energy Services Ltd. (FES Ltd) is an independent oilfield services contractor that provides a range of well site services to oil and natural gas drilling and producing companies to help develop and enhance the production of oil and natural gas. These services include fluid hauling, fluid disposal, well maintenance, completion services, workovers and recompletions, plugging and abandonment, and tubing testing. FES Ltd operates in two segments: well servicing and fluid logistics and other. Its operations are concentrated in the onshore oil and natural gas producing regions of Texas, with additional locations in Mississippi, in Pennsylvania and, prior to the disposition of its Mexican assets in January 2012, which is discussed below, in Mexico. In January 2012, the Company sold its assets located in Mexico, as well as its equity interests in Forbes Energy Services Mexico Servicios de Personal, S. de R.L. de C.V. Advisors' Opinion:
  • [By CRWE]

    Forbes Energy Services Ltd. (NASDAQ:FES), a leader in well servicing and fluid logistics management in the oilfield services industry, will participate in the GHS 100 Energy Conference being held June 25-26, 2012, at the Intercontinental Hotel in San Francisco.

5 Best Up And Coming Stocks To Own Right Now: Peerless Systems Corporation(PRLS)

Peerless Systems Corporation holds the right to license imaging and networking technologies and components to the digital document markets. It licenses technologies and components for the original equipment manufacturers of color and monochrome printers, and multifunction office products. The company was founded in 1982 and is headquartered in Stamford, Connecticut.

Advisors' Opinion:
  • [By Monica Gerson]

    Peerless Systems Corporation (NASDAQ: PRLS) agreed to be acquired by Mobius Acquisition, LLC for $7.00 per share in cash. Peerless Systems shares jumped 27.25% to $6.72 in the after-hours trading session.

5 Best Up And Coming Stocks To Own Right Now: The Navigators Group Inc.(NAVG)

The Navigators Group, Inc., together with its subsidiaries, engages in underwriting ocean marine, property and casualty, professional liability, and specialty insurance products and services. The company?s marine and inland marine insurance products include marine and energy liability, cargo, craft/fishing vessel, bluewater hull, brownwater hull, protection and indemnity, war, customs bonds, commercial output policy, construction, transportation, specialty, specie, and marine excess-of-loss reinsurance Its property and casualty insurance products comprise general and environmental liability, umbrella and excess, offshore energy, onshore energy, operational engineering, construction, life sciences, exporters package liability, accident and health reinsurance, Latin America property and casualty reinsurance, agriculture reinsurance, professional liability reinsurance, bloodstock, and the U.S. casualty insurance products. The company?s professional liability products inclu de directors and officers, employment practices, fiduciary, crime, accountants professional, lawyers professional, insurance agent errors and omissions, miscellaneous professional, technology and media, design professionals, and real estate agent liability insurance products. The Navigators Group, Inc. distributes its products through global, national, and regional retail and wholesale insurance brokers. The company was founded in 1981 and is based in Rye Brook, New York.

Advisors' Opinion:
  • [By Ben Levisohn]

    Tower Group has dropped 12% to $3.88 today at 11:39 a.m., while Stewart Information Services (STC) has dipped 0.1% to $31.16, the�Navigators Group�(NAVG) has fallen 1.4% to $54.78 and HCI Group�(HCI) has gained 1% to $38.16.

Tuesday, June 9, 2015

Top 10 European Companies To Buy For 2015

Networking giant Cisco Systems (CSCO) reported better-than-expected fourth-quarter results on August 13, outdoing the Street�� expectations and own guidance as well. Let�� have a deeper look into the quarter�� results and find out about the company�� future roadmap.

Revenue decline moderates

Cisco�� fourth-quarter revenue of $12.4 billion was roughly flat compared with the year-ago quarter. Solid geographical contributions (except from emerging economies) and improved sales of some product lines helped the company to avoid year over year revenue decline against expectations. The company had predicted its revenue to decline in the range of 1%-3%.

On the product front, almost all the product lines generated weak revenues that were compensated by strong deployment of its data center solutions. Data center business grew significantly by 30% year over year. The company posted 5% growth in its services revenue driven by large deal wins.

Geographically, revenue from the Americas grew 2% with most of the strength coming from the U.S. Within the U.S., revenues from commercial and enterprise businesses shot up by 17% and 16%. Revenues from these two businesses recorded growths of 7% and 8%, respectively, in Europe, the Middle East and Africa, driven by strength across European countries.

Top 5 Paper Companies To Invest In Right Now: British American Tobacco Industries p.l.c.(BTI)

British American Tobacco p.l.c., through its subsidiaries, engages in the manufacture, distribution, and sale of tobacco products. The company offers cigars, cigarettes, smokeless snus, roll-your-own, and pipe tobacco products under the Dunhill, Kent, Lucky Strike, Pall Mall, Vogue, Viceroy, Kool, Rothmans, Peter Stuyvesant, Benson & Hedges, and State Express 555 brand names. It has operations in the Asia-Pacific, the Americas, eastern and western Europe, Africa, and the Middle East. The company was founded in 1902 and is headquartered in London, the United Kingdom. British American Tobacco p.l.c. operates independently of Remgro Ltd. as of November 03, 2008.

Advisors' Opinion:
  • [By Ben Levisohn]

    Given the size of a potential acquisition of Lorillard would be quite large, we question how a bid from [Reynolds American] would be financed. Therefore, we think a more likely deal could be a merger between [Lorillard] and�[Reynolds American] rather than an acquisition. Also, there has been speculation that British American Tobacco (BTI), which currently owns ~42% of�[Reynolds American's] stock, could take a majority stake in�[Reynolds American] after the standstill ends in July 2014. While we believe the most likely scenario is that [British American Tobacco] and�[Reynolds American] could reach a strategic partnership to market/sell e-cigs globally, we wouldn�� rule out�[British American Tobacco] taking a majority stake in [Reynolds American]. Furthermore, if this occurs,�[British American Tobacco] could help finance a potential acquisition of [Lorillard].

Top 10 European Companies To Buy For 2015: Flamel Technologies S.A.(FLML)

Flamel Technologies S.A., a biopharmaceutical company, engages in the development and commercialization of controlled-release therapeutic products based on its proprietary polymer based technology in the United Kingdom, Ireland, the United States, France, and Europe. The company develops nanogel Medusa technology, which is intended to provide controlled release following injection of therapeutic proteins, peptides, and other molecules; a microparticle adaptation of the Medusa platform that is intended for use in the delivery of smaller proteins and peptides; and Micropump technology, a microparticle technology for oral administration of small molecule drugs with applications in controlled-release, taste-masking, and bioavailability enhancement; and Trigger-Lock technology, an adaptation based on Micropump technology, which is intended to minimize the misuse and abuse of medications subject to abuse. Its principal product based on Micropump technology is Coreg CR, which is intended for the treatment of moderate to severe heart failure and left ventricular dysfunction following myocardial infarction. The company?s products under development based upon Medusa technology include Interferon-alpha, a naturally occurring protein that the body uses for the treatment of Hepatitis C virus and as a immune response; and FT-105, an injectable insulin formulation for diabetic patients. Its products based on its Micropump technology comprise LiquiTime for the elderly and pediatric patient patients, or others who have difficulty swallowing. The company has strategic alliance with Baxter International, Inc.; GlaxoSmithKline; Merck Serono; and Pfizer Inc, as well as has a joint development agreement with Digna Biotech, S.L. Flamel Technologies S.A. was founded in 1990 and is headquartered in Venissieux, France.

Advisors' Opinion:
  • [By Anna Prior]

    Flamel Technologies SA(FLML) said the U.S. Food and Drug Administration has approved the company’s new drug application for Vazculep, an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. American depositary shares rose 5.1% to $14.78 in premarket trading.

  • [By Garrett Cook]

    Healthcare shares gained 0.81 percent in the US market on Friday. Top gainers in the sector included Shire plc (NASDAQ: SHPG), StemCells (NASDAQ: STEM), and Flamel Technologies SA (NASDAQ: FLML).

  • [By Garrett Cook]

    Healthcare shares gained 0.81 percent in the US market on Friday. Top gainers in the sector included Shire plc (NASDAQ: SHPG), StemCells (NASDAQ: STEM), and Flamel Technologies SA (NASDAQ: FLML).

Top 10 European Companies To Buy For 2015: TotalFinaElf S.A.(TOT)

TOTAL S.A., together with its subsidiaries, operates as an integrated oil and gas company worldwide. The company operates through three segments: Upstream, Downstream, and Chemicals. The Upstream segment engages in the exploration, development, and production of oil and natural gas. It also involves in the transportation, trade, and marketing of natural gas and liquefied natural gas (LNG), as well as in LNG re-gasification and natural gas storage operations. In addition, this segment engages in the shipping and trade of liquefied petroleum gas (LPG); power generation from gas-fired power plants, nuclear, or renewable energies; production, trade, and marketing of coal, as well as in solar power systems and technology operations. As of December 31, 2010, it had combined proved reserves of 10,695 Mboe of oil and gas. The Downstream segment involves in refining, marketing, trading, and shipping crude oil and petroleum products. It also produces a range of specialty products, s uch as lubricants, LPG, jet fuel, special fluids, bitumen, marine fuels, and petrochemical feedstock. This segment holds interests in 24 refineries located in Europe, the United States, the French West Indies, Africa, and China, as well as operates a network of 17,490 service stations. The Chemicals segment produces base chemicals, including petrochemicals and fertilizers, as well as engages in rubber processing, resins, adhesives, and electroplating activities. TOTAL S.A. was founded in 1924 and is based in Paris, France.

Advisors' Opinion:
  • [By Robert Rapier]

    Seadrill Partners is presently the only offshore drilling services company structured as a partnership, although international offshore drilling contractor�Ocean Rig�(Nasdaq: ORIG) has plans to drop down assets into an MLP this year. The Seadrill Partners IPO involved a drop down of four drilling rigs from the parent — two semi-submersibles (the West Aquarius and the West Capricorn), one tender rig (the West Vencedor), and one ultra-deepwater drillship (the West Capella). These drilling rigs are under long-term contracts with major oil companies such as�Chevron�(NYSE: CVX),�Total�(NYSE:TOT),�BP�(NYSE: BP) and�ExxonMobil�(NYSE: XOM).

Top 10 European Companies To Buy For 2015: Fresenius Medical Care Corporation (FMS)

Fresenius Medical Care AG & Co. KGaA, a dialysis company, provides products and services for patients with chronic kidney diseases. As of May 12, 2011, it provided dialysis care services to 216,942 patients through its network of 2,769 dialysis clinics primarily in North America, Europe, Latin America, the Asia-Pacific, and Africa. The company also develops and manufactures various dialysis products, including hemodialysis machines, dialyzers, hemofilters, dialysis fluid filters, tubing systems, fistula needles, dialysis related equipment, acute hemodialysis machines, plasma filters, acute tubing systems and cassettes, catheters, and related disposable products for chronic hemodialysis, acute therapy, home therapy, and therapeutic apheresis, as well as dialysis drugs. In addition, it provides laboratory services. Fresenius Medical sells its products through distributors. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.

Advisors' Opinion:
  • [By Ben Eisen]

    DaVita (DVA) �gained 8.9% and Fresenius (FMS) �rose 7.2%.

  • [By Johanna Bennett]

    Dialysis provider DaVita Healthcare Partners (DVA) soared almost 8.9% to close at $61.55 after the market learned that Medicare funding cuts would come in lower than expected. Rival Fresenius Medical Care (FMS) rose 7.2% on the same news.

  • [By Johanna Bennett]

    The Centers for Medicare and Medicaid decided today to cut government payment to dialysis clinics. So why did share prices for DaVita HealthCare Partners (DVA) and rival Fresenius Medical Care (FMS) rise so steeply today?

  • [By Louie Grint]

    Still unaffected
    First, Fresenius Medical Care (NYSE: FMS  ) is the No. 1 global provider of dialysis equipment. It enjoys leading market share of almost 33% in its home country.

Top 10 European Companies To Buy For 2015: STMicroelectronics N.V.(STM)

STMicroelectronics N.V., an independent semiconductor company, engages in the design, development, manufacture, and marketing of a range of semiconductor integrated circuits and discrete devices. Its products include discrete and standard commodity components, application-specific integrated circuits, custom devices and semi-custom devices, and application-specific standard products for analog, digital, and mixed-signal applications. The company also offers subsystems and modules for the telecommunications, automotive, and industrial markets comprising mobile phone accessories, battery chargers, ISDN power supplies, and in-vehicle equipment for electronic toll payment, as well as provides Smartcard products. Its products are used in various microelectronic applications consisting of automotive products, computer peripherals, telecommunications systems, consumer products, industrial automation, and control systems. The company sells its products through distributors and ret ailers. STMicroelectronics N.V. was founded in 1987 and is headquartered in Geneva, Switzerland.

Advisors' Opinion:
  • [By Evan Niu, CFA]

    STMicroelectronics (NYSE: STM  ) and OmniVision (NASDAQ: OVTI  ) are the two camera suppliers, and HTC is reportedly no longer considered a "tier one" manufacturer so it doesn't get priority any more. That implies that one of these image sensor specialists was giving HTC the cold shoulder in favor of bigger names.

  • [By MONEYMORNING]

    In 2009, Ericsson hooked up with STMicroelectronics NV (NYSE ADR: STM) - Europe's No. 1 chipmaker - to produce semiconductors for the wireless market. Launched in 2009, this also was ill-fated.

  • [By John Udovich]

    If you are looking for a semiconductor stock that�� focus on an area that�� not so cyclical, mid cap microcontroller (MCU) stock Atmel Corporation (NASDAQ: ATML) could be a good choice���meaning its worth taking a closer look at the stock along with other�microcontroller�players like Microchip Technology Inc (NASDAQ: MCHP), STMicroelectronics N.V. (NYSE: STM) and Cypress Semiconductor Corporation (NASDAQ: CY). Microcontrollers are programmable and�embedded�chips that are increasingly�hidden inside a all sorts of products these days e.g. if you have an appliance�with a�LED or LCD screen and a keypad, it contains some kind of�microcontroller plus all new�automobiles contain at least one�and often several. I should mention that we have also recently added Atmel Corporation to our SmallCap Network Elite Opportunity (SCN EO) portfolio and we are down about 5.6% mostly due to the recent market volatility.

Top 10 European Companies To Buy For 2015: BP p.l.c.(BP)

BP p.l.c. provides fuel for transportation, energy for heat and light, retail services, and petrochemicals products. Its Exploration and Production segment engages in the oil and natural gas exploration, field development, and production; midstream transportation, and storage and processing; and marketing and trading of natural gas, including liquefied natural gas (LNG), and power and natural gas liquids (NGL). This segment has exploration and production activities in Angola, Azerbaijan, Canada, Egypt, Norway, Russia, Trinidad and Tobago, the United Kingdom, and the United States, as well as in Asia, Australasia, South America, North Africa, and the Middle East. This segment also owns and manages crude oil and natural gas pipelines; processing facilities and export terminals; and LNG processing and transportation, as well as NGL extraction facilities. BP p.l.c. has interests in the Trans-Alaska pipeline system, the Forties pipeline system, the Central Area transmission sys tem pipeline, the South Caucasus Pipeline, and Baku-Tbilisi-Ceyhan pipeline, as well as in LNG plants located in Trinidad, Indonesia, and Australia. The company?s Refining and Marketing segment involves in the supply and trading, refining, manufacturing, marketing, and transportation of crude oil, petroleum, and petrochemicals products and related services to wholesale and retail customers primarily under the BP, Castrol, ARCO, and Aral brands. Its Other Businesses and Corporate segment produces and markets rolled aluminum products, as well as generates energy through wind, solar, biofuels, hydrogen, and carbon capture and storage sources; and engages in shipping activities. The company was founded in 1889 and is headquartered in London, the United Kingdom.

Advisors' Opinion:
  • [By Dividend Growth Investor]

    The company�� last dividend increase was in April 2013 when the Board of Directors approved a 10.50% increase to 63 cents/share. The company�� largest competitors include Chevron (CVX), British Petroleum (BP) and Royal Dutch (RDS.B). In late 2012, I replaced Exxon Mobil with a position in ConocoPhillips.

  • [By Matt DiLallo]

    It should come as no surprise that demand for ultra-deep-water rigs is�strong in the Gulf now that the industry is finally moving past the BP (NYSE: BP  ) disaster. Oil companies have been investing heavily in the region and those investments are starting to bear fruit. Earlier this year ConocoPhillips (NYSE: COP  ) and its partners announced two major oil discoveries, Shenandoah and Coronado, which could be added to as the company plans to drill another five wells this year. The company has amassed over 2 million net acres in the Gulf, a position it recently added to as the company was the highest bidder on 30 blocks which added 172,000 net acres to its position. Needless to say, Conoco is expecting big things from its investments in the Gulf.�

  • [By Damian Illia]

    In a previous article we saw the 13-F's holdings of Absolute Return Investors. Here, let麓s analyze one of them, Chevron Corporation (CVX), and see if it is appropriate to be in that long portfolio. The firm does not need too much introduction. The company�� upstream operations include exploring, developing and producing crude oil and natural gas, and processing, liquefaction, transportation and regasification associated with liquefied natural gas. The company�� downstream operations include refining crude oil into petroleum products, and manufactures and markets commodity petrochemicals, plastics for industrial uses and fuel and lubricant additives. The firm's largest competitors include BP Plc (BP) and Exxon Mobil Corp (XOM).

  • [By Dividends4Life]

    Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number CVX is trading at a discount to only 3.) above. The stock is trading at a 44.9% premium to its calculated fair value of $82.00. CVX did not earn any Stars in this section. Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% CVX earned two Stars in this section for 2.) and 3.) above. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. CVX earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1912 and has increased its dividend payments for 27 consecutive years. Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA The NPV MMA Diff. of the $256 is below the $800 target I look for in a stock that has increased dividends as long as CVX has. The stock's current yield of 3.37% exceeds the 3.31% estimated 20-year average MMA rate. Memberships and Peers: CVX is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: BP plc (BP) with a 4.7% yield, Exxon Mobil

Top 10 European Companies To Buy For 2015: Telefonica SA(TEF)

Telefonica, S.A. provides fixed and mobile telephony services primarily in Spain, rest of Europe, and Latin America. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone; local, domestic, and international long distance and fixed-to-mobile communications; corporate communications; video telephony; supplementary and business-oriented value-added services; network services; leasing and sale of handset equipment; and telephony information services. The company?s Internet and broadband multimedia services comprise Internet service provider service; portal and network services; retail and wholesale broadband access; narrowband switched access to Internet; naked ADSL, a broadband connection; residential-oriented value-added services; companies-oriented value-added services; television services, such as IPTV, cable television, and satellite television; and Fiber to the Home, a service for high speed Internet access and digital video recording. Its data and business-solutions services principally include leased lines; virtual private network services; fiber optics services; the provision of hosting and application; outsourcing and consultancy services; desktop services; and system integration and professional services. The company?s wholesale services for telecommunication operators primarily comprise domestic interconnection services; international wholesale services; leased lines for other operators? network deployment; local loop leasing under the unbundled local loop regulation framework; and bit stream services. It also offers various mobile and related services and products that include mobile voice services, value added services, mobile data and Internet services, wholesale services, corporate services, roaming, fixed wireless, and trunking and paging services. The company has a strategic alliance with China Unicom (Hong Kong) Limited. Telefonica, S.A. was founded in 1924 and is headquartered in Madrid, Spai n.

Advisors' Opinion:
  • [By Amy Thomson]

    AT&T has examined takeover candidates including Vodafone�� assets, U.K. mobile carrier EE -- a venture of Deutsche Telekom AG (DTE) and Orange SA (ORA) -- and parts of Spain�� Telefonica SA (TEF), people familiar with the company�� plans said in June. AT&T is attracted to Europe because of its relatively recent introduction of faster, fourth-generation networks, which have been available for years in the U.S.

  • [By Eric Volkman]

    Ebix (NASDAQ: EBIX  ) will be very busy in the near future doing work for a major South American telecom incumbent. The company announced that it has signed a deal with Telefonica's (NYSE: TEF  ) Brazilian subsidiary Telefonica/Vivo (NYSE: VIV  ) , also known as Telefonica Brasil,�to supply its services for the latter's eHealth Self Care initiative, which aims "to provide health assistance and complimentary services to their millions of clients." Ebix will utilize its A.D.A.M. Health Content Exchange solution to make this happen.

Best India Stocks To Invest In 2016

Best India Stocks To Invest In 2016: Sify Technologies Limited(SIFY)

Sify Technologies Limited provides enterprise and consumer Internet services primarily in India. The company offers various corporate network/data services comprising e-commerce and network connectivity solutions, such as end-to-end services network, application, and security services; voice origination and termination services; co-location and managed hosting services; and system integration services for data centre build, hardware distribution, security solutions, and turnkey projects. It also provides application services, including SLEMS and Microsoft Exchange messaging platforms; I-test for online assessment and LiveWire, which enable management of training processes across the organization; document management system for the management of documents electronically; and Forum, a forward supply chain solution. In addition, the company operates e-Ports that offer browsing, chat, email, gaming, utility bill payment, travel ticketing, hotel booking, mobile recharge, Intern et telephony, and online share trading services; and portals, which provide news, views, reviews, interactions, and services in the areas of movies, sports, finance, food, videos, astrology, online games, shopping, and travel, as well as offers content offerings and broadband services. Further, it provides infrastructure management services, such as network management, datacenter and helpdesk outsourcing, desktop and storage outsourcing, IT security outsourcing, LAN and WAN outsourcing, database and telecom outsourcing, and application monitoring and management services to automotive, chemical, media, and financial enterprises; and virtualization design, integration, and deployment services for servers, storage, networks, and end user clients. Sify has approximately 1,278 e-Ports in 200 towns and cities; and serves 1,06,000 broadband subscribers through 1500 cable TV Operators. The company, formerly known as Sify Limited, was founded in 1995 and is based! in Chennai, India. Advisors' Opinion:

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Technology stocks gained Tuesday, with Ku6 Media Co (NASDAQ: KUTV) leading advancers. Among leading tech stocks, gains came from Rubicon Technology (NASDAQ: RBCN), Bitauto Holdings (NYSE: BITA) and Sify Technologies (NASDAQ: SIFY). Utilities shares dropped by 0.11 percent in the US market today.

  • source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/best-india-stocks-to-invest-in-2016.html

Sunday, June 7, 2015

Best High Tech Stocks To Own Right Now

Best High Tech Stocks To Own Right N ow: Select Sector Financial Select Sector SPDR Fund (XLF)

Financial Select Sector SPDR Fund (the Fund) seeks to provide investment results that correspond to the price and yield performance of the Financial Select Sector of the S&P 500 Index (the Index). The Index includes financial service firms with diversified business lines ranging from investment management to commercial and investment banking.

The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Funds investment advisor is SSgA Funds Management, Inc.

Advisors' Opinion:
  • [By Ben Levisohn]

    Financial stocks are taking the brunt of the damage this morning. The Financial Select Sector SPDR ETF (XLF) has dropped 1.1% to $129.83 at 9:38 a.m., making it the biggest loser among sector ETFs. Visa (V) and American Express (AXP) have dropped 1.8% and 1.7%, to lead the Dow lower.

  • source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/best-high-tech-stocks-to-own-right-now-4.html